Latest Lymphocyte Stories
In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development.
Blue Ocean Biomedical introduces the LG Series Flow Cytometry Systems, the first fully automated, load & go systems for counting CD4 cells and other lymphocyte subsets. Pembroke Pines, FL (PRWEB) July 15, 2011 Blue Ocean Biomedical introduces the LG Series Flow Cytometry Systems, the first fully automated, load & go systems for counting CD4 cells and other lymphocyte subsets.
Scientists at the Salk Institute for Biological Studies have developed an improved technique for generating large numbers of blood cells from a patient's own cells.
After eight years of work, researchers have unearthed what has been a well-kept secret of our immune system's success.
Researchers at the Stanford University School of Medicine have taken a machine already in use for the measurement of impurities in semiconductors and used it to analyze immune cells in far more detail than has been possible before.
ROCKVILLE, Md., April 28, 2011 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART(TM) antibody technology. Included in the peer-reviewed article titled, "Application of...
BRISBANE, Calif., March 24, 2011 /PRNewswire/ -- SARcode Corporation announced today that clinical data for their lead compound, SAR 1118, has been accepted for presentation during the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 1-May 5, 2011, in Fort Lauderdale, Florida.
New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.
DURHAM, N.C., Jan.
Lycera Corporation, a biopharmaceutical company pioneering an innovative approach to developing novel oral medicines to treat autoimmune diseases, today announced positive data from the University of Michigan demonstrating the role of bioenergetics in selectively inhibiting pathogenic lymphocytes while preserving and enhancing the normal immune system.
- An imitative word; an onomatopoetic word.